Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice TargetHot
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $251 to $274.
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $251 to $274.